EUVIMEDEUVIMED entdecken
Crossref

Eye-drops in therapy – facts and myths about preservatives

Dorota Szumny

OphthaTherapy. Therapies in Ophthalmology · 2024

DOI: 10.24292/01.ot.041124 ↗

Kurz gefasst

Fachartikel in der Zeitschrift OphthaTherapy. Therapies in Ophthalmology, 2024. Verfasst von Dorota Szumny.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Drugs in ophthalmology are most often applied topically in the conjunctival sac. All preparations administered through this route must meet specific requirements and, therefore, not just a simple solution or suspension of the drug in water. In addition to the therapeutic substance, eye drops contain various additives: buffers, preservatives, stabilisers, antioxidants, and isotonic substances to increase solubility and viscosity. Excipients are essential components of drugs that determine their quality and properties and can increase the effectiveness of treatment, e.g. by increasing the penetration of the drug through biological barriers. However, because of the high demands placed on ocular medicines, the choice of excipients is very limited. This article discusses the facts and myths surrounding the use of excipients, including preservatives, in eye drops.

Zitieren

APA

Szumny, D. (2024). Eye-drops in therapy – facts and myths about preservatives. OphthaTherapy. Therapies in Ophthalmology. https://doi.org/10.24292/01.ot.041124

Vancouver

Szumny D. Eye-drops in therapy – facts and myths about preservatives. OphthaTherapy. Therapies in Ophthalmology. 2024. doi:10.24292/01.ot.041124

BibTeX
@article{Szumny2024,
  author = {Szumny, Dorota},
  title = {Eye-drops in therapy – facts and myths about preservatives},
  journal = {OphthaTherapy. Therapies in Ophthalmology},
  year = {2024},
  doi = {10.24292/01.ot.041124}
}
Kostenlos starten →